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making them more susceptible to fracture than healthy
bones. In order to maintain a healthy skeleton, a steady-
state of bone remodeling occurs in adults in which new
bone is generated at the same rate that old bone is
removed. The remodeling process is important for
maintaining bone strength because it adapts the
structure of bone to mechanical loads (2). In
osteoporosis, the rate of bone resorption exceeds that of
the formation, resulting in a progressive deterioration of
bone mass and microarchitecture (2).
There are the two kinds of bone that comprise the
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INTRODUCTION
Osteoporosis is defined by the World Health
Organization (WHO) as having a bone mineral density
(BMD) of more than 2.5 standard deviations below the
norm for healthy young adults (1). BMD, measured by
dual-energy X-ray absorptiometry, is used as a bone
mass index to predict the risk of fracture (1).
Osteoporotic bones are porous and fragile, thus
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ABSTRACT: It is estimated that osteoporosis is responsible for about 300 000 hip fractures per year in
the United States. Effective prevention of these fractures has been demonstrated using bisphosphonates.
However, their mechanism of action has not been elucidated. Furthermore, the precise effect of
bisphosphonates on the femoral neck and surrounding areas has never been studied.
We are interested in establishing a protocol to analyze the bone quality of proximal femurs from
patients treated with bisphosphonates. Following hip replacement surgery, the aim is to determine
whether imaging and compression testing of cancellous bone from the discarded femoral necks can
accurately assess the bone’s microarchitectural and biomechanical properties, respectively. 
To validate the technique, it was first tested on an untreated population. A bone biopsy trephine was
used to extract cylindrical cores of trabecular bone from the centre of femoral necks. Densitometry,
microcomputed tomography, and compression testing were used to assess the quality of bone in these
samples. The compressive strength was found to be directly proportional to the modulus (i.e. stiffness)
of the samples, thus reproducing previous findings. The relative porosity and, to a lesser extent, the bone
mineral density were capable of predicting the quality of cancellous bone. In conclusion, a protocol to
analyze the bone quality in human femoral necks using µCT and biomechanical compression testing
was successfully established. It will be applied in a clinical setting to analyze bones from
bisphosphonate-treated patients following total hip replacement.
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skeleton are compact and cancellous (i.e. trabecular).
Compact bone predominates in the appendicular
skeleton and is designed to resist bending forces. On the
other hand, cancellous bone is concentrated in the axial
skeleton and is structured to resist compressive forces,
including gravity. Since it is lighter and more porous
than compact bone, cancellous bone provides more
surface area for bone remodeling and is more
metabolically active (2). Consequently, cancellous bone
is more affected in osteoporosis (3).
One class of drugs aimed at preventing bone loss is
bisphosphonates. Bisphosphonates, including
alendronate and risedronate, are antiresorptive agents
which are stable analogues of inorganic pyrophosphate
and have a high affinity for hydroxyapatite crystals.
They bind selectively to mineralized surfaces of bone to
disrupt degradative osteoclast activity and promote
apoptosis of mature osteoclasts (4). Bisphosphonates
are also thought to prolong the life of osteoblasts by
inhibiting apoptosis (5). 
Alendronate and risedronate are highly effective in
decreasing the risk of vertebral and hip fractures (6-8).
But, it was also demonstrated that the observed increase
in BMD in bisphosphonate-treated patients does not
entirely account for the reduction in fracture risk (6).
Therefore, the mechanism of action of bisphosphonates
has not yet been elucidated. In fact, it is hypothesized
that bisphosphonates may act by increasing bone mass,
improving trabecular microarchitecture, and/or
increasing secondary mineralization of the calcified
matrix (9). Recently, more emphasis has been placed on
the concept of "bone quality" which encompasses the
microarchitectural and biomechanical properties of
bone (10, 11).
It is estimated that osteoporosis is responsible for
about 300 000 hip fractures per year in the United States
(12). Recent studies have shown that hip-fractured
patients rapidly lose bone density within 6 months after
fracture, possibly because of the absence of weight
bearing for 6 weeks post-operatively and the fact that
peri-prosthetic bone loss rapidly occurs following hip
arthroplasty (13). Since there is no standard of care for
the prevention and the treatment of osteoporosis in
these patients, our interest is to determine the best
approach to prevent bone loss in this group. As the
effect of bisphosphonates on the femoral neck and
surrounding areas has not yet been assessed, we will
analyze the bone quality of proximal femurs from
treated patients that are discarded after hip replacement
surgery. Prior to undertake these clinical trials, however,
protocols must be established in an untreated population
in order to properly assess the quality of bone.
This project aims to determine whether imaging and
compression testing of cancellous bone from the
femoral neck can accurately assess the bone’s
microarchitectural and biomechanical properties,
respectively, and if together they will serve as a good
index of bone quality.
MATERIALS AND METHODS
Twenty-two bovine (calf) femurs were obtained from
a butcher (Boucherie Charcuterie Rivière des Prairies,
Montreal, QC). Nineteen human proximal femurs were
collected by Dr. Michael Tanzer (Montreal General
Hospital, Montreal, QC) and Dr. William Fisher
(Montreal General Hospital, Montreal, QC) from total
hip replacement orthopedic surgeries. Patients signed
consent forms for the donation of their tissue. All
samples were wrapped in gauze and soaked in saline to
prevent drying. The specimens were frozen at -30ºC
until bone core extraction (14). 
Prior to sample preparation, the femurs were thawed
at 4ºC overnight. A Rochester Bone Biopsy Trephine
(Item #87400-000, Gauthier Medical Inc., Rochester,
MN) 7.5mm in diameter was used to extract cylindrical
cores of trabecular bone from the centre of the femoral
necks. Both ends of the cores were cut at right angles to
the long axis in order to minimize shearing during
biomechanical compression testing (15). The
dimensions of the trabecular bone cores were 7.5mm in
diameter by 14mm in length, thereby maintaining a
valid aspect ratio between 1.5 and 2 (16). The cores
were placed in 70% ethanol prior to testing (17).
The trabecular bone cores were scanned using a
Lunar PIXImus densitometer (Lunar Corp, Madison,
WI) at the Bone Centre (McGill University, Montreal,
QC) to measure the bone mineral density (BMD) for a
region of interest inside the specimen (11.3mm x 5mm).
They were subsequently scanned with a micro-
computed tomography (µCT) instrument (Model 1072,
Skyscan, Aartselaar, Belgium) at the Bone Centre
(McGill University, Montreal, QC). The cross-sections
along the specimen axis were reconstructed using Cone-
Beam Reconstruction software (SkyScan), with a
distance between each cross-section of 18.25µm. The
CT-Analyser software (SkyScan) was used to analyze
the trabecular bone of the sample using segmentation
method. 
The bone cores were then subjected to the
compression testing. Specimens were mounted on the
testing machine (Instron 5569, Buckinghamshire, UK)
so that the long axes of the cylinders were perpendicular
to the lower anvil. A compressive force was then
applied to the upper surface of the samples using a
50kN load cell at a constant crosshead displacement
rate of 1 mm/min until failure occurred. The
compressive load and the sample length were recorded
at 0.1 second intervals during compression. Using this
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data, the Stress (Force/Area) and Strain
(Length/Original Length) were calculated and plotted
against one another. The Elastic Modulus, an indication
of the extent of compressive deformation in a specimen
for a given load, was obtained from the linear portion of
the Stress versus Strain curve (15).
RESULTS
Initially, it was imperative to demonstrate that the
protocol used to retrieve cylindrical cores of cancellous
bone would provide valid samples for biomechanical
testing. Twenty two cores of cancellous bone were
extracted from the femoral neck of calf femurs and
subjected to compression testing. The compressive
strength and the elastic modulus were calculated for
each sample and plotted against each other. It should be
noted that the compressive strength is a measure of the
stress within a sample immediately before the yielding
point, while the elastic modulus is a measure of the
rigidity of a sample. In concordance with previous
findings, the compressive strength correlates strongly to
the modulus (r = 0.98) in the calf femur samples (see
Figure 1) (18). Furthermore, these parameters fall
within the range of published bovine values (19). 
Upon validating our technique, the same procedure
was applied to the human femoral neck samples
obtained from hip replacement surgeries. Nineteen
human samples were obtained and tested. Comparable
to the bovine samples, the compressive strength and the
modulus of the human samples are strongly correlated
(r = 0.99), as demonstrated in Figure 2. Moreover, the
values for these parameters fall within the range of
published human values for the femoral neck (20).
Prior to subjecting the human cancellous samples to
biomechanical testing, they were scanned using three
dimensional µCT and densitometry. As demonstrated in
Figure 3, the osteoporotic bone appears much more
porous than the unaffected bone. The compressive
strength was plotted against the trabecular thickness,
number and separation, as shown in Figure 4. The latter
parameters failed to show any statistically significant
relationship to the biomechanics of bone. The trabecular
thickness and separation remained fairly constant
despite the strength of the bone, whereas the number of
trabeculae appeared to increase with the compressive
strength although not well. Needless to say, the
trabecular data proved to be poor indicators of bone
quality.
Further investigation of the imaging data revealed
that the relative porosity, calculated as the complement
of the percent bone volume (i.e. 1 - % bone volume),
and the BMD were the best predictors of bone quality.
In fact, the relative porosity and the BMD correlated
strongly to one another (see Figure 5, r = 0.97). Upon
analyzing the data, the compressive strength and the
modulus were shown to vary exponentially with relative
porosity and the BMD. That is to say, the strength and
the modulus of the samples increased at a faster rate as
the relative porosity decreased or the BMD increased.
Thus, the latter were plotted against the natural
logarithms of the compressive strength and the modulus
for each bone sample (see Figures 6-9). The relative
porosity and the BMD correlated equally well to the
compressive strength and the modulus (Ln(compressive
strength) vs. relative porosity, r = -0.90; Ln(modulus)
vs. relative porosity, r = -0.88; Ln(compressive
strength) vs. BMD, r = 0.94; Ln(modulus) vs. BMD, r =
0.92).
DISCUSSION
The assessment of bone quality is of the utmost
importance in osteoporotic patients as it correlates well
to the risk of fracture (1) and indicates when it is
appropriate to initiate the proper preventative measures
(6-8). Bisphosphonates have proven to be quite
successful in deterring the progression of osteoporosis
(6). However, their precise mechanism of action has yet
to be determined. Recently, there have been trials that
have studied the effect of risedronate in osteoporotic
patients using µCT (11). These studies have indirectly
assessed the drug's effect on bone quality using a remote
site (i.e. the iliac crest) rather than the site of interest
(e.g. vertebrae, femoral neck). Understandably, the
analysis of the iliac crest is convenient because it is
easily accessible from the surface and poses minimal
risk to the patient. There has been, however, no
evidence to indicate whether any correlation exists
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Figure 1: Compressive strength versus Modulus in cancellous bone
from calf femoral necks. Both parameters are measured in
MegaPascals (MPa). Correlation coefficient, r = 0.98105 2006
between the microarchitecture at the iliac crest and the
site of interest. To our knowledge, the effects of
bisphosphonates on bone quality have not yet been
studied in humans at sites than at the iliac crest. 
Prior to embarking on a hip fracture study, we wanted
to establish reliable and reproducible procedures for
biomechanical testing to ensure that the data were valid
and representative of bone quality. Intuitively, bone
quality should diminish as the bone becomes more
porous and/or less dense with mineral. Indeed, we
found the relative porosity and the BMD to be equally
strong indicators of bone quality as both of these
parameters correlate strongly to the biomechanical
properties of bone, though in opposite fashion (see
Figures 6-9). 
A potential limitation to this experiment is the
inherent design flaw that results from the extraction of
trabecular bone. As the cylindrical core of bone is
removed from the sample, the cross struts from the
trabeculae along the periphery are severed. This
unavoidably compromises structural integrity,
especially since the compact bone significantly
contributes to the overall strength of the femur (21).
Hence, the biomechanical studies will not be entirely
representative of the properties of trabeculae within the
bone. However, taking into consideration that all the
samples are prepared identically before testing, the data
analysis remains valid.
CONCLUSION
We have successfully established a protocol that will
be used in a trial setting to analyze the bone quality in
human femoral necks using µCT and biomechanical
compression testing. Using cores of cancellous bone
from human femoral necks, the relative porosity and the
BMD were shown to be excellent predictive markers of
fracture resistance. As this trial evolves in its early
stages, additional samples collected from hip
replacements will be tested and the data compiled to
construct a reference database for comparison to
bisphosphonate treatment cohorts. 
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Figure 2: Compressive strength versus Modulus in cancellous bone
from human femoral necks. Both parameters are measured in
MegaPascals (MPa). Correlation coefficient, r = 0.99.
Figure 3: Computer-generated three dimensional images of
unaffected bone (left panel) and osteoporotic bone (right panel) from
µCT scans.
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Figure 4: Trabecular thickness (Tr.Thick, circles), number (Tr.Num,
squares),  and separation (Tr.Sep, triangles) plotted  against
Compressive  Strength in MegaPascals (MPa).  Trabecular  thickness
and separation  are  measured  in  millimeters  (mm)  and  trabecular
number is measured as  the quantity of trabeculae per millimeter
(mm-1).106 Quality of Canellous Bone Vol. 9  No. 2
REFERENCES
1. WHO, Assessment of fracture risk and its application to
screening for postmenopausal osteoporosis, in Report of a WHO
study group. WHO technical report series no. 8430. 1994, World
Health Organization: Geneva, Switzerland.
2. Boonen, S., et al., Preventing osteoporotic fractures with
antiresorptive therapy: implications of microarchitectural
changes. J Intern Med, 2004; 255(1): p. 1-12.
3. Seeman, E., Invited Review: Pathogenesis of osteoporosis. J
Appl Physiol, 2003; 95(5): p. 2142-51.
4. Russell, R.G., et al., The pharmacology of bisphosphonates and
new insights into their mechanisms of action. J Bone Miner Res,
1999; 14(Suppl 2): p. 53-65.
5. Manolagas, S.C., Birth and death of bone cells: basic regulatory
mechanisms and implications for the pathogenesis and treatment
of osteoporosis. Endocr Rev, 2000; 21(2): p. 115-37.
6. Black, D.M., et al., Randomised trial of effect of alendronate on
risk of fracture in women with existing vertebral fractures.
0.10
0.15
0.20
0.25
0.30
0.35
0.6 0.7 0.8 0.9
Relative Porosity
B
M
D
 
(
g
/
c
m
2
)
r = -0.97
Figure 5: BMD plotted against Relative Porosity. Correlation
coefficient, r = -0.97. 
0
1
2
3
0.6 0.7 0.8 0.9
Relative Porosity
L
n
 
(
C
o
m
p
r
e
s
s
i
v
e
 
S
t
r
e
n
g
t
h
)
r = -0.90
Figure 6: The natural logarithm of Compressive Strength plotted
against Relative Porosity. Correlation coefficient, r = -0.90.
3
4
5
6
7
0.6 0.7 0.8 0.9
Relative Porosity
L
n
 
(
M
o
d
u
l
u
s
)
r = -0.88
Figure 7: The natural logarithm of Modulus plotted against Relative
Porosity. Correlation coefficient, r = -0.88.
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Figure 8: The natural logarithm of Compressive Strength plotted
against BMD. Correlation coefficient, r = 0.94.
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Figure 9: The natural logarithm of Modulus plotted against BMD.
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